Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
about
Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Splenectomy vs. rituximab as a ...... a: a single center experience.
@en
Splenectomy vs. rituximab as a ...... a: a single center experience.
@nl
type
label
Splenectomy vs. rituximab as a ...... a: a single center experience.
@en
Splenectomy vs. rituximab as a ...... a: a single center experience.
@nl
prefLabel
Splenectomy vs. rituximab as a ...... a: a single center experience.
@en
Splenectomy vs. rituximab as a ...... a: a single center experience.
@nl
P2093
P2860
P1476
Splenectomy vs. rituximab as a ...... ra: a single center experience
@en
P2093
Altaf Khan
Bader S Al Qahtani
Faris Ahmed
Ismat Kamran
May Anne Mendoza
Mohammed G Al Otaibi
Mohand Al Zughaibi
Mohsen Al Zahrani
Naila A Shaheen
P2860
P2888
P356
10.1007/S12185-017-2325-Y
P577
2017-09-11T00:00:00Z